| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.5B | $0.4B | $0.4B | $0.2B | — |
| Cost of Revenue | $0.6B | $0.5B | $0.4B | $0.3B | $0.3B | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $0.6B | $0.6B | $0.5B | $0.4B | $0.3B | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | $-0.0B |
| Net Income | $0.5B | $0.5B | $-0.3B | $-0.3B | $-0.5B | $-0.0B |
| EPS (Basic) | $0.42 | $0.46 | $-0.36 | $-0.40 | $-1.00 | — |
| EPS (Diluted) | $0.39 | $0.39 | $-0.36 | $-0.40 | $-1.00 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $50.7B | $36.3B | $30.1B | $19.0B | $9.2B | $0.8B |
| Current Assets | — | — | — | — | — | $0.0B |
| Cash & Equivalents | $4.9B | $2.5B | $3.1B | $1.4B | $0.5B | $0.0B |
| Total Liabilities | $40.2B | $29.7B | $24.5B | $13.5B | $4.5B | $0.0B |
| Current Liabilities | — | — | — | — | — | $0.0B |
| Stockholders' Equity | $10.5B | $6.5B | $5.2B | $5.2B | $4.4B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-3.7B | $-1.1B | $-7.2B | $-7.3B | $-1.4B | $-0.0B |
| Investing Cash Flow | $-6.7B | $-4.8B | $-1.9B | $-0.1B | $0.1B | $-0.8B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $13.1B | $5.0B | $10.9B | $8.4B | $0.7B | $0.8B |